Tetra Bio-Pharma Inc. (OTCMKTS:TBPMF) has announced the commencement of the synthetic cannabinoid therapy (PPP003v) clinical trials for ophthalmic eye pain treatment in the veterinary environment. Proof...
Tetra Bio Pharma Inc (OTCMKTS:TBPMF) has issued an update on the clinical trial of the PPP003 Ophthalmic drug to treat eye pain in companion animals. During...
Health Canada has granted two Over the Counter (OTC) identification numbers to Tetra Bio Pharma Inc (OTCMKTS:TBPMF). This grant allows Tetra Bio to market its first...
Tetra Bio-Pharma Inc. (OTCQB:TBPMF) has achieved considerable progress in the clinical trial of PPP005, the cannabis oil derived capsules targeted for natural health products. The company...